Renflexis is biologic therapy that is indicated for treating
- moderately to severely active ulcerative colitis
- moderately to severely active Crohn’s disease
- moderately to severely active rheumatoid arthritis
- plaque psoriasis
- psoriatic arthritis
- ankylosing spondylitis
Renflexis is a biosimilar medication to Remicade.
Renflexis blocks the action of the immune protein TNF-alpha.
This helps to alleviate inflammation that causes symptoms.
Renflexis is administered via infusion in three starting doses within the first six weeks of your treatment.
After the initial six weeks, patients will receive infusions once every six to eight weeks, or every four weeks for some patients with rheumatoid arthritis.
Patients choose Red Bank Infusion Center
to have their Renflexis therapy because
- of our flexible, worry-free scheduling, with evening and weekend appointments available
- our all-private infusion suites, with the latest COVID safety standards in place for your protection
- equipped with medical-grade, leather recliners, with chairs and amenities for your guests
- including large, flat screen TVs, free WiFi and entertainment channels for your viewing pleasure
- and our friendly, helpful clinical staff providing personalized service
Want to move to
Red Bank Infusion Center?
We make it simple and convenient for you to start your infusion care with us.
